Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-114

@I'll drinktothat agreed we are certainly owed a lot of info like:-

- What's the update on NT Cell and why were the 2 year results declared a failure as a price sensitive announcement and then redefined in reality a success ...but played down via a 'non price sensitive' announcement apparently at LCT's request to ASX. ?
- How is the data at 2 1/2 years for cohorts 1 and 2.?
- what happened to the Medsafe response they were expecting by May?
- How is the Pathogen status of the pigs that was being tested in April?
- Did anything come of the cited discussions with possible JV partners at all the conferences LCT attended?
- plans , scope and financials for the phase 3 trial if to go ahead .....

I think they should also decide whether to continue with the concept of Newsletters which are at best 'ad hock' and maybe put anything tangeable achieved in the quarterlies. These currently carry only financial updates and no activity statements . ie Commit to newsletters on a set frequency or abandon the idea.
They should also make a decision on the web site - give somebody the task to keep it up to date or abandon that also as continually carrying outdated information says a lot about the company.

Hopefully all will become clear very soon but I am a tad sceptical. !